biological immunotherapy - using natural killer cells [nk] to fight viral infections & tumors
Published 5 years ago • 1.6K plays • Length 3:58Download video MP4
Download video MP3
Similar videos
-
23:41
exploiting unexpected nad metabolic vulnerabilities in ppm1d-mutant gliomas
-
2:04
updated long-term follow-up of sequoia: zanubrutinib vs bendamustine-rituximab in untreated cll/sll
-
2:18
prolonging survival in nsclc
-
6:43
molecular testing in patients with metastatic nsclc
-
3:26
sugemalimab plus platinum-based chemotherapy for metastatic non-small-cell lung cancer
-
3:25
impact of radiation dose to immune cells in unresectable or stage iii nsclc in the durvalumab era
-
3:39
a 62-year-old woman with braf v600e metastatic nsclc
-
3:08
a case of nondriver metastatic lung large cell carcinoma
-
3:47
pembrolizumab as treatment for oligometastatic nsclc
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
6:13
systemic treatment of non-oncogene addicted nsclc with brain metastases
-
1:47
lobar vs. sublobar resection for peripheral stage ia nsclc | nejm
-
9:16
changing treatment paradigm for braf-mutant nsclc
-
2:18
hsp 90 inhibitors and the treatment of lung cancer
-
9:23
mutation testing for all patients with nsclc
-
15:17
oncotarget: retaining nanomolar potency in lung cancer with therapy-refractory mutations
-
4:29
non–small cell lung cancer: other actionable mutations
-
13:26
debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
-
2:42
a 68-year-old man with metastatic egfr nsclc